More on CAMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.4 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/19/26)
- M&A (6/30/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CAMP4 Therapeutics (NQ:CAMP)
Delayed: 3.39 +0.10 (3.04%)
Prev. Close $3.29  
Open$3.20 
52 Wk High$21.34 
52 Wk Low$12.13 
Day High$3.50 
Day Low$3.20 
P/E 2.55  
EPS$1.33 
Volume141,127 

Friends, Peers and Foes (?): A68, STH XFOR (more...)

Oct 15, 2026 05:23 AM Needham Starts CAMP4 Therapeutics Corp (CAMP) at Buy
Oct 14, 2026 08:00 AM CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
Oct 5, 2026 06:58 AM Oppenheimer Starts CAMP4 Therapeutics Corp (CAMP) at Outperform
Sep 29, 2026 07:18 AM CAMP4 Therapeutics (CAMP) Reiterated at Overweight by Cantor Fitzgerald After Analyst Day
Sep 29, 2026 06:10 AM CAMP4 Therapeutics Corp (CAMP) PT Lowered to $6 at Chardan
Sep 10, 2026 07:33 AM Camp4 Therapeutics gets UK approval for SYNGAP1 drug trial
Sep 10, 2026 07:33 AM CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
Sep 8, 2026 04:05 PM CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Sep 1, 2026 04:05 PM CAMP4 to Participate in Upcoming Investor Conferences
Aug 26, 2026 04:58 PM Form 4 Camp4 Therapeutics Corp For: Aug 24 Filed by: Schwab Andrew J.
View All Articles

Entities mentioned with CAMP

View All Entities